Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemia.
Seth E KarolTodd M CooperPaul E MeadKristine R CrewsJohn C PanettaThomas B AlexanderJeffrey W TaubNorman J LacayoKenneth M HeymDennis John KuoDeborah E SchiffDeepa BhojwaniYubin GeJeffery M KlcoRaul C RibeiroHiroto InabaChing-Hong PuiJeffrey E RubnitzPublished in: Cancer (2020)
Panobinostat can be safely administered with chemotherapy and results in increased blast histone acetylation. This suggests that it should be further studied in AML.